Blog

TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration News & Insights | September 1, 2026 TruWay Health is advancing FUSION-72: Multimodal Digital Biomarker Prediction of Acute Deterioration, a research initiative conducted under TH-FUSION72-2026-001. The study is focused on an emerging area of clinical research: understanding whether combinations of digital biomarkers and longitudinal clinical signals can help identify patterns associate …